Interleukin Inhibitors Market to Grow at 12.01% CAGR, Projected to Surge Beyond USD 25.09 Billion

The global interleukin inhibitors market is being fueled by an increase in the prevalence of chronic inflammatory illnesses such as arthritis, psoriasis, and asthma. Furthermore, the market is being boosted by a growth in FDA approvals for novel medications and therapies for the treatment of chronic inflammatory diseases.